Angiogenesis

David A. Cheresh P.C. Brooks, S. Strömblad, L.C. Sanders, T.L. von Schalscha, R.T. Aimes, W.G. Stetler-Stevenson, J.P. Quigley, D.A. Cheresh, "Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha-vß3," Cell, 85:683-93, 1996. (Cited in more than 155 papers since publication) Comments by David A. Cheresh, professor of immunology and vascular biology at the Scripps Research Institute in La Jolla, Calif. Much in the new

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share


David A. Cheresh

P.C. Brooks, S. Strömblad, L.C. Sanders, T.L. von Schalscha, R.T. Aimes, W.G. Stetler-Stevenson, J.P. Quigley, D.A. Cheresh, "Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha-vß3," Cell, 85:683-93, 1996. (Cited in more than 155 papers since publication)

Comments by David A. Cheresh, professor of immunology and vascular biology at the Scripps Research Institute in La Jolla, Calif.

Much in the news of late, angiogenesis, the formation of blood vessels during embryogenesis, tissue repair, and the spread of tumors, has been billed as an excellent target for cancer-fighting therapies. Recent studies by the authors of this paper have identified the integrin alpha-vß3 --one of a family of cell-adhesion molecule receptors--as a therapeutic target on angiogenic blood vessels. As part of as-yet-unpublished studies, they've also gone on to evaluate antagonists of this integrin in Phase I and Phase II clinical trials in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies